Semen

Urologist Dr. Justin Dubin Sparks Conversations on Male Factor Infertility, Providing Expert Answers to Common Questions

Retrieved on: 
Monday, June 19, 2023
Men, Other Health, General Health, Social Media, Family, Consumer, Other Education, Other Communications, Fitness & Nutrition, Education, Parenting, Communications, Health, Exercise, Heart, Learning, Male, Pressure, Memorial Hermann Health System, Diabetes, DSM-IV codes, Varicocele, Infection, Urology, Semen, Infertility, Guilt, Children's right to adequate nutrition in New Zealand, Vegetable, Movement, Lubricant, Shame, Fertility, Testosterone, Cystic fibrosis, Overweight, Prohibition, WHO, Smoking, Kidney disease, Female, Birth control, Dietary supplement

Despite approximately 40 to 50 percent of all infertility cases occurring due to male factor infertility, a lack of education and stigma surrounding male infertility remains.

Key Points: 
  • Despite approximately 40 to 50 percent of all infertility cases occurring due to male factor infertility, a lack of education and stigma surrounding male infertility remains.
  • , answers common questions about male factor infertility, clarifies its causes, discusses lifestyle factors, and provides guidance on when to seek advice from a healthcare provider.
  • “Male factor infertility affects roughly half of all infertility cases, yet there is a pervasive stigma surrounding male infertility that prevents many men from seeking help,” says Dr. Dubin.
  • However, by opening the conversation, we can break the silence around male infertility and encourage men to take control of their reproductive health.”
    Below, Dr. Dubin answers common questions regarding male factor infertility:
    What are the common causes of male infertility?

AAV Vector Shedding Assay-- Best Practices in Clinical Gene Therapy Method Development, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Monday, June 5, 2023
Trial of the century, Saliva, Plasma, Doctor of Philosophy, Drug development, Semen, Molecule, Urine, Blood, AAV, Molecular and Cellular Biology, Vaccine, MCB

TORONTO, Ontario, Canada, June 5, 2023 /PRNewswire-PRWeb/ -- Gene therapies have demonstrated to be life-changing therapies for many devastating diseases. The drug development path is not always straightforward and regulatory guidance is often vague about the details of some requirements. One of the requirements in clinical development is to monitor vector shedding to control the potential environmental risk associated with the therapy. The assay read-out is qualitative, providing the sponsor and investigator with the relevant information about vector-shedding clearance after therapy. A sensitive and reliable method is needed in several different matrices, usually including blood, plasma, faeces, semen, urine and saliva. This webinar will cover unique requirements and challenges in developing vector shedding assays like the AAV shedding assay, with applications.

Key Points: 
  • In this free webinar, learn about the unique requirements and challenges in developing vector shedding assays like the AAV shedding assay, with applications.
  • Attendees will get a review of best practices for developing a suitable qPCR-based vector shedding assay and how that data can be used and interpreted during the clinical study.
  • One of the requirements in clinical development is to monitor vector shedding to control the potential environmental risk associated with the therapy.
  • This webinar will cover unique requirements and challenges in developing vector shedding assays like the AAV shedding assay, with applications.

Global $815+ Million Sperm Separation Devices Market to 2028: Increasing Knowledge and Attitude Towards Advanced Reproductive Treatments - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 1, 2023
Medical Devices, Health, Male, Prevalence, Semen, ART, Infertility, Research, USD, IVF, Hospital, Fertility, Insemination, Nanotechnology, Birth control, Video game

The global sperm separation devices market is expected to reach a value of $816.5 million by 2028 from $478.18 million, growing at a CAGR of 9.33%

Key Points: 
  • The global sperm separation devices market is expected to reach a value of $816.5 million by 2028 from $478.18 million, growing at a CAGR of 9.33%
    In reproductive health and sperm separation devices, several new technologies have been addressed in recent years that deliver lucrative market growth opportunities.
  • One of the rapidly accepting technologies in sperm separation devices is "Microfluidic Sperm Sorting Chips," an easy, cost-effective, and better clinical outcome-providing technology expected to drive sperm separation devices market growth.
  • Healthy and motile sperm separation procedures commonly performed by the sperm separation devices in IVF labs which expected to drive the sperm separation devices market growth during the forecast period.
  • The global sperm separation devices market by hospitals and clinics was valued at USD 165.88 million in 2022.

Mothers' lives in ancient Greece were not easy – but celebrations of their love have survived across the centuries

Retrieved on: 
Tuesday, May 9, 2023
Odyssey, Heart, Uncertainty, Male, Life, Parent, Tears, Marriage, Semen, Woman, Mother, Sophocles, Student, Man, Holiday, Grief, Time, Child, Hera, Mortality, Infant, Death, Andromache, Toy, Birth control, Entertainment, Thetis, Euripides

But my work as a scholar of ancient Greek literature has shown me how much harder it was to be a mother in antiquity.

Key Points: 
  • But my work as a scholar of ancient Greek literature has shown me how much harder it was to be a mother in antiquity.
  • Thanks in part to their connection to the life cycle, women in ancient Greece were both symbols of mortality and a force to humanize heroes.

Historical lives

    • What we know of women’s lives in ancient Greece is generally not good.
    • We have uncertain evidence for what lives were like after marriage.
    • Most historians agree that child loss was common enough in antiquity to be an expectation rather than a surprise.
    • As a parent, however, I am less convinced that high rates of loss led parents to be more distant.

Women in stories

    • When people think of the field I study, epic poetry, I suspect they generally think of violent male heroes and victimized women.
    • While this image is certainly not wrong, it overlooks other ways that women, and mothers in particular, were crucial to the world of Greek poetry and myth.
    • During his brief visit to speak with the dead, he learns that his mother, Anticleia, died of a broken heart over his long absence.
    • Heroic mothers helped ancient Greeks define themselves and understand their place in the world, almost always to their own detriment.

Human Identification Market Report 2022: Rising Adoption of Forensic Applications Bolsters Growth

Retrieved on: 
Thursday, March 23, 2023
Molecular biology, Component, DNA, Hair, Laboratory, QIAGEN, Ear, ARUP Laboratories, Chromatin, NGS, ICMP, Semen, Intelligence, Research, Genomics, RNA, Proteomics, Qiagen, Cloud computing, ARUP, Investment, Application, Blood, Crime, Growth, Skin, Video game

The global human identification market is anticipated to observe impressive growth during the forecast period, 2023-2027.

Key Points: 
  • The global human identification market is anticipated to observe impressive growth during the forecast period, 2023-2027.
  • Also, the strategic initiatives such as partnerships and product launches undertaken by the market players are augmenting the growth of the market.
  • The increasing use of forensic applications is fueling the growth of the global human identification market.
  • In this report, global human identification market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

American Urological Association Announces Innovation Nexus Showcase Selections

Retrieved on: 
Tuesday, March 14, 2023
Nexus, Face, Urology, Acute kidney injury, Male, Histology, Vital signs, Perineum, Funding of science, Patient, Overactive bladder, Semen, Interstitial cystitis, AUA, Cryopreservation, Patient satisfaction, American Urological Association, Nocturnal enuresis, BCG, Quality of life, Bladder cancer, FACS, Child, Biology, Showcase, Prostate, OAB, Video game, Medical device, Fair, Medical imaging, MD

BALTIMORE, March 14, 2023 /PRNewswire/ -- The American Urological Association (AUA) is pleased to announce the ten companies chosen through a rigorous and highly competitive selection process for the inaugural Innovation Nexus Showcase. The Showcase gives investigators, startups and mid-size companies the opportunity to pitch their ideas to a panel of individuals and corporations looking to invest in urology.  

Key Points: 
  • BALTIMORE, March 14, 2023 /PRNewswire/ -- The American Urological Association (AUA) is pleased to announce the ten companies chosen through a rigorous and highly competitive selection process for the inaugural Innovation Nexus Showcase.
  • Innovation Nexus is a long-term commitment by the AUA to sustain a urology incubator to advance discoveries with key stakeholders for the benefit of urologic patient care.
  • "Beyond the next generation innovation that these showcase selections represent, we are excited about the international reach as well as the breadth and depth of urologic conditions that this cohort represents."
  • For more information on the Showcase and to register to attend the April 27 event, please visit: https://auanexus.org/

Clinical Research by Anderson Biotests, LLC, in Collaboration With the Bedford Research Foundation, Suggests New Paradigm for Determining Vasectomy Success

Retrieved on: 
Thursday, February 16, 2023
Woman, Physician, Anderson, Law of the United Kingdom, Supreme court, Semen, Patient, Bedford Research Foundation, Vasectomy, Roe v. Wade, Collection, Birth control

This requirement is thought to account for the poor compliance (about 43% of patients) with post-vasectomy semen analyses.

Key Points: 
  • This requirement is thought to account for the poor compliance (about 43% of patients) with post-vasectomy semen analyses.
  • Although vasectomy is a more successful sterility procedure than tubal ligation of women, vasectomy has been employed by fewer than 10% of couples seeking non-hormonal birth control.
  • The home collection kit itself is manufactured by Anderson Biotest and features a patented preservative that stabilizes the semen specimen for transport back to the lab for sperm count.
  • Submission of two kits to fully verify the absence of sperm is recommended by physicians and professional societies.

DelveInsight Evaluates a Robust Prostate Cancer Pipeline as 170+ Influential Pharma Players to Set Foot in the Domain

Retrieved on: 
Thursday, February 16, 2023
ZEN, ADC, Plantar fibromatosis, Safety, Eli Lilly and Company, Acquisition, Merck & Co., Lung, BioNTech, CSPC, Clinical trial, Carcinoma, Prostate cancer, Bristol Myers Squibb, Cancer, John Engen, SCNC, Breast, Pain, Regeneron Pharmaceuticals, GT0918, SE, Lymph, Semen, Advaxis, Growth, Society, AstraZeneca, LAS, ASCO, Janssen Pharmaceuticals, PARP, Urination, Human, Blood, United Kingdom, Therapy, Diagnosis, Common, MRI, Patient, PSMA, Ejaculation, Merck, Nivolumab, Tissue, Biopsy, Free trade areas in Europe, Shijiazhuang Pharma Group, Amgen, Urine, Magnetic resonance imaging, Neoplasm, European, TCE, Dairy, Pharmaceutical industry, Medical imaging, Bayer, Pfizer, Pembrolizumab

LAS VEGAS, Feb. 16, 2023 /PRNewswire/ -- DelveInsight's 'Prostate Cancer Pipeline Insight – 2023' report provides comprehensive global coverage of available, marketed, and pipeline prostate cancer therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the prostate cancer pipeline domain.

Key Points: 
  • The rise in the number of cases of prostate cancer has led to growing government funding and rising initiatives by public and private organizations to spread awareness about prostate cancer.
  • The emergence of strong pipeline drugs and the presence of novel prostate cancer treatments are the prominent factors that will escalate the growth rate of the prostate cancer therapeutics market.
  • LAS VEGAS, Feb. 16, 2023 /PRNewswire/ -- DelveInsight's ' Prostate Cancer Pipeline Insight – 2023 ' report provides comprehensive global coverage of available, marketed, and pipeline prostate cancer therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the prostate cancer pipeline domain.
  • DelveInsight's prostate cancer pipeline report depicts a robust space with 170+ active players working to develop 200+ pipeline therapies for prostate cancer treatment.

Industry’s First Male Fertility Platform Posterity Health Raises $7.5M in an Oversubscribed Funding Round Led by Distributed Ventures

Retrieved on: 
Tuesday, January 17, 2023
Health, Other Health, Descendant, Semen, FCA, OBGYN, Semen analysis, Association of British HealthTech Industries, Weill Cornell Medicine, Distribution, Patient, Yale University, Physician, UCSF, Fertility, Birth control, Urology, Male

Posterity Health , the only digital male fertility center of excellence that offers personalized advice, educational resources, and effective male fertility treatments, today announced an oversubscribed funding round of $7.5M led by early-stage venture capital fund Distributed Ventures .

Key Points: 
  • Posterity Health , the only digital male fertility center of excellence that offers personalized advice, educational resources, and effective male fertility treatments, today announced an oversubscribed funding round of $7.5M led by early-stage venture capital fund Distributed Ventures .
  • The new capital will accelerate the company’s Digital Health Platform and provide access to male fertility testing and treatment on a national scale.
  • This expansion has been crisply synchronized to capitalize on the new male fertility benefits that became effective on January 1, 2023.
  • “This funding allows us to move one step closer to achieving our mission to provide access to male fertility care for every couple trying to conceive,” said Pam Pure , CEO of Posterity Health.

The Worldwide Allergic Conjunctivitis Industry is Estimated to Reach $2.9 Billion by 2031 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 4, 2023
Health, Optical, Conjunctivitis, Allergic conjunctivitis, Allergy, Conjunctiva, Allergen, Market share, Common, Allergic rhinitis, Eyelid, Urbanization, Porter's five forces analysis, Pollen, Itchy, Gonorrhea, National Centre for Cold-chain Development, Semen, Growth, Patient, Benchmarking, Vertically transmitted infection, Asthma, Distribution, Spore, Eye, STI, Asthma and Allergy Foundation of America, Prevalence, Chlamydia, Cosmetics, Marketing

The global allergic conjunctivitis market was valued at $1,937.99 million in 2021, and is estimated to reach $2,954.2 million by 2031, growing at a CAGR of 4.28% from 2022 to 2031.

Key Points: 
  • The global allergic conjunctivitis market was valued at $1,937.99 million in 2021, and is estimated to reach $2,954.2 million by 2031, growing at a CAGR of 4.28% from 2022 to 2031.
  • An allergic reaction to things such as pollen, mold, or spores can result in an eye inflammation known as allergic conjunctivitis.
  • The major factors that drive the growth of the allergic conjunctivitis market are increase in patient population suffering from ocular allergies.
  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the allergic conjunctivitis market analysis from 2021 to 2031 to identify the prevailing allergic conjunctivitis market opportunities.